English

CytoCore Inc

EDGAR

CYOE Quarterly report (10-Q) · filed 2018-11-14

119 filing records in this dataset, filed from 1995-08-14 to 2018-11-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

2.39 million USD

2018 Q3 · USD

Exact inputs and evidence

Revenue: 2394000 USD Source

Operating margin

-3.97%

2018 Q3 · %

Exact inputs and evidence

Operating Income: -95000 USD Source
Revenue: 2394000 USD Source

Operating cash flow

-821 thousand USD

2018 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -3477000 USD Source
Operating Cash Flow: -2656000 USD Source

Cash and cash equivalents: 147 thousand USD 2018-09-30 Source
Exact value

147000 USD
Long-term debt including current maturities: 5.1 million USD 2018-09-30 Source
Exact value

5100000 USD
Shares outstanding: 74.6 million shares 2018-09-30 Source
Exact value

74646201 shares

Reported share-count change

158.69% · 45.8 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

28855580 shares · 2017-09-30· Source
74646201 shares · 2018-09-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2018-11-14.

Financial data available through: 2017-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2017-12-31
Operating income: 11 of 11 periods available· newest 2017-12-31
Net income: 11 of 11 periods available· newest 2017-12-31
Operating cash flow: 11 of 11 periods available· newest 2017-12-31
Capital expenditure: 4 of 11 periods available· newest 2010-12-31
Total assets: 11 of 11 periods available· newest 2017-12-31
Total liabilities: 5 of 11 periods available· newest 2017-12-31
Current assets: 11 of 11 periods available· newest 2017-12-31
Current liabilities: 11 of 11 periods available· newest 2017-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2017-12-31
Long-term debt including current maturities: 4 of 11 periods available· newest 2017-12-31
Shares outstanding: 8 of 11 periods available· newest 2017-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-26.3%

Prior period

USD 9.24 million

2016-01-01 – 2016-12-31
Current period

USD 6.81 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

6813000 − 9238000 = -2425000 USD

9238000 USD · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
6813000 USD · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CytoCore Inc · 2017-12-31 CytoCore Inc (edgar:75439) Year-over-year change in Revenue: -2425000 USD Concept: fundies:Revenue Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 6813000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000165495418005606/mdit-20171231.xml#492891 Filing: 000165495418005606 Input fundies:Revenue: 9238000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000165495418005606/mdit-20171231.xml#493005 Filing: 000165495418005606
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 4.65 million

Prior period

−USD 2.16 million

2016-01-01 – 2016-12-31
Current period

−USD 6.81 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

-6811000 − -2163000 = -4648000 USD

-2163000 USD · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
-6811000 USD · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CytoCore Inc · 2017-12-31 CytoCore Inc (edgar:75439) Year-over-year change in Net income: -4648000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -6811000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000165495418005606/mdit-20171231.xml#90850 Filing: 000165495418005606 Input fundies:NetIncome: -2163000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000165495418005606/mdit-20171231.xml#90975 Filing: 000165495418005606
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 2.48 million

Prior period

−USD 1.09 million

2016-01-01 – 2016-12-31
Current period

−USD 3.57 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

-3569000 − -1091000 = -2478000 USD

-1091000 USD · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
-3569000 USD · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CytoCore Inc · 2017-12-31 CytoCore Inc (edgar:75439) Year-over-year change in Operating cash flow: -2478000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -3569000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000165495418005606/mdit-20171231.xml#96164 Filing: 000165495418005606 Input fundies:OperatingCashFlow: -1091000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000165495418005606/mdit-20171231.xml#96347 Filing: 000165495418005606
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2017 2017-01-01 – 2017-12-31

Revenue USD 6.81 million 100% of revenue
Operating costs Derived USD 13.29 million 195% of revenue
Operating income −USD 6.48 million −95% of revenue
Tax, interest and other Derived USD 331,000 4.9% of revenue
Net income −USD 6.81 million −100% of revenue

Cash

Operating cash flow −USD 3.57 million −52% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2008 Operating loss: operating costs were 5,198% of revenue.
2009 Operating loss: operating costs were 7,591% of revenue.
2010 Operating loss: operating costs were 7,600% of revenue.
2011 Operating loss: operating costs were 10,846% of revenue.
2012 Operating loss: operating costs were 741% of revenue.
2013 97%
2014 Operating loss: operating costs were 104% of revenue.
2015 Operating loss: operating costs were 106% of revenue.
2016 Operating loss: operating costs were 118% of revenue.
2017 Operating loss: operating costs were 195% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2008 2008-01-01 – 2008-12-31	125000	6497000 Derived	-6372000	-44000 Derived	-6328000	-8662000 Derived	Source 2008-01-01 – 2008-12-31: 125000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -6372000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -6328000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -7118000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 1544000 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	44000	3340000 Derived	-3296000	256000 Derived	-3552000	-1647000 Derived	Source 2009-01-01 – 2009-12-31: 44000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -3296000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -3552000 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -1637000 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 10000 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	30000	2280000 Derived	-2250000	-153000 Derived	-2097000	-1121000 Derived	Source 2010-01-01 – 2010-12-31: 30000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -2250000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -2097000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -1121000 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 0 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	24000	2603000 Derived	-2579000	297000 Derived	-2876000	Unavailable	Source 2011-01-01 – 2011-12-31: 24000 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -2579000 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -2876000 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -719000 USD Inspect Operating Cash Flow Open source
2012 2012-01-01 – 2012-12-31	198000	1467000 Derived	-1269000	245000 Derived	-1514000	Unavailable	Source 2012-01-01 – 2012-12-31: 198000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -1269000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -1514000 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -685000 USD Inspect Operating Cash Flow Open source
2013 2013-01-01 – 2013-12-31	9958000	9664000 Derived	294000	240000 Derived	54000	Unavailable	Source 2013-01-01 – 2013-12-31: 9958000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: 294000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: 54000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -404000 USD Inspect Operating Cash Flow Open source
2014 2014-01-01 – 2014-12-31	10983000	11377000 Derived	-394000	305000 Derived	-699000	Unavailable	Source 2014-01-01 – 2014-12-31: 10983000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -394000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -699000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -891000 USD Inspect Operating Cash Flow Open source
2015 2015-01-01 – 2015-12-31	9887000	10486000 Derived	-599000	260000 Derived	-859000	Unavailable	Source 2015-01-01 – 2015-12-31: 9887000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -599000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -859000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -388000 USD Inspect Operating Cash Flow Open source
2016 2016-01-01 – 2016-12-31	9238000	10899000 Derived	-1661000	502000 Derived	-2163000	Unavailable	Source 2016-01-01 – 2016-12-31: 9238000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -1661000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -2163000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -1091000 USD Inspect Operating Cash Flow Open source
2017 2017-01-01 – 2017-12-31	6813000	13293000 Derived	-6480000	331000 Derived	-6811000	Unavailable	Source 2017-01-01 – 2017-12-31: 6813000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -6480000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -6811000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -3569000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 6.8M 2017

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Revenue	125000	Revenue: 125000 Open source
20092009-12-31	Revenue	44000	Revenue: 44000 Open source
20102010-12-31	Revenue	30000	Revenue: 30000 Open source
20112011-12-31	Revenue	24000	Revenue: 24000 Open source
20122012-12-31	Revenue	198000	Revenue: 198000 Open source
20132013-12-31	Revenue	9958000	Revenue: 9958000 Open source
20142014-12-31	Revenue	10983000	Revenue: 10983000 Open source
20152015-12-31	Revenue	9887000	Revenue: 9887000 Open source
20162016-12-31	Revenue	9238000	Revenue: 9238000 Open source
20172017-12-31	Revenue	6813000	Revenue: 6813000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-26.3% 2017

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Year over year	50.6%	Revenue: 125000 Open source Revenue: 83000 Open source
20092009-12-31	Year over year	-64.8%	Revenue: 44000 Open source Revenue: 125000 Open source
20102010-12-31	Year over year	-31.8%	Revenue: 30000 Open source Revenue: 44000 Open source
20112011-12-31	Year over year	-20%	Revenue: 24000 Open source Revenue: 30000 Open source
20122012-12-31	Year over year	725%	Revenue: 198000 Open source Revenue: 24000 Open source
20132013-12-31	Year over year	4,929.3%	Revenue: 9958000 Open source Revenue: 198000 Open source
20142014-12-31	Year over year	10.3%	Revenue: 10983000 Open source Revenue: 9958000 Open source
20152015-12-31	Year over year	-10%	Revenue: 9887000 Open source Revenue: 10983000 Open source
20162016-12-31	Year over year	-6.6%	Revenue: 9238000 Open source Revenue: 9887000 Open source
20172017-12-31	Year over year	-26.3%	Revenue: 6813000 Open source Revenue: 9238000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -95.1% 2017

Net margin -100% 2017

Free cash flow margin -3,736.7% 2010

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Operating margin	-5,097.6%	Operating Income: -6372000 Open source Revenue: 125000 Open source
20092009-12-31	Operating margin	-7,490.9%	Operating Income: -3296000 Open source Revenue: 44000 Open source
20102010-12-31	Operating margin	-7,500%	Operating Income: -2250000 Open source Revenue: 30000 Open source
20112011-12-31	Operating margin	-10,745.8%	Operating Income: -2579000 Open source Revenue: 24000 Open source
20122012-12-31	Operating margin	-640.9%	Operating Income: -1269000 Open source Revenue: 198000 Open source
20132013-12-31	Operating margin	3%	Operating Income: 294000 Open source Revenue: 9958000 Open source
20142014-12-31	Operating margin	-3.6%	Operating Income: -394000 Open source Revenue: 10983000 Open source
20152015-12-31	Operating margin	-6.1%	Operating Income: -599000 Open source Revenue: 9887000 Open source
20162016-12-31	Operating margin	-18%	Operating Income: -1661000 Open source Revenue: 9238000 Open source
20172017-12-31	Operating margin	-95.1%	Operating Income: -6480000 Open source Revenue: 6813000 Open source
20082008-12-31	Net margin	-5,062.4%	Net Income: -6328000 Open source Revenue: 125000 Open source
20092009-12-31	Net margin	-8,072.7%	Net Income: -3552000 Open source Revenue: 44000 Open source
20102010-12-31	Net margin	-6,990%	Net Income: -2097000 Open source Revenue: 30000 Open source
20112011-12-31	Net margin	-11,983.3%	Net Income: -2876000 Open source Revenue: 24000 Open source
20122012-12-31	Net margin	-764.6%	Net Income: -1514000 Open source Revenue: 198000 Open source
20132013-12-31	Net margin	0.5%	Net Income: 54000 Open source Revenue: 9958000 Open source
20142014-12-31	Net margin	-6.4%	Net Income: -699000 Open source Revenue: 10983000 Open source
20152015-12-31	Net margin	-8.7%	Net Income: -859000 Open source Revenue: 9887000 Open source
20162016-12-31	Net margin	-23.4%	Net Income: -2163000 Open source Revenue: 9238000 Open source
20172017-12-31	Net margin	-100%	Net Income: -6811000 Open source Revenue: 6813000 Open source
20082008-12-31	Free cash flow margin	-6,929.6%	Revenue: 125000 Open source Operating Cash Flow: -7118000 Open source Capital Expenditure: 1544000 Open source
20092009-12-31	Free cash flow margin	-3,743.2%	Revenue: 44000 Open source Operating Cash Flow: -1637000 Open source Capital Expenditure: 10000 Open source
20102010-12-31	Free cash flow margin	-3,736.7%	Revenue: 30000 Open source Operating Cash Flow: -1121000 Open source Capital Expenditure: 0 Open source
20112011-12-31	Free cash flow margin	Not reported	Revenue: 24000 Open source Operating Cash Flow: -719000 Open source
20122012-12-31	Free cash flow margin	Not reported	Revenue: 198000 Open source Operating Cash Flow: -685000 Open source
20132013-12-31	Free cash flow margin	Not reported	Revenue: 9958000 Open source Operating Cash Flow: -404000 Open source
20142014-12-31	Free cash flow margin	Not reported	Revenue: 10983000 Open source Operating Cash Flow: -891000 Open source
20152015-12-31	Free cash flow margin	Not reported	Revenue: 9887000 Open source Operating Cash Flow: -388000 Open source
20162016-12-31	Free cash flow margin	Not reported	Revenue: 9238000 Open source Operating Cash Flow: -1091000 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 6813000 Open source Operating Cash Flow: -3569000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -3.6M 2017

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Operating cash flow	-7118000	Operating Cash Flow: -7118000 Open source
20092009-12-31	Operating cash flow	-1637000	Operating Cash Flow: -1637000 Open source
20102010-12-31	Operating cash flow	-1121000	Operating Cash Flow: -1121000 Open source
20112011-12-31	Operating cash flow	-719000	Operating Cash Flow: -719000 Open source
20122012-12-31	Operating cash flow	-685000	Operating Cash Flow: -685000 Open source
20132013-12-31	Operating cash flow	-404000	Operating Cash Flow: -404000 Open source
20142014-12-31	Operating cash flow	-891000	Operating Cash Flow: -891000 Open source
20152015-12-31	Operating cash flow	-388000	Operating Cash Flow: -388000 Open source
20162016-12-31	Operating cash flow	-1091000	Operating Cash Flow: -1091000 Open source
20172017-12-31	Operating cash flow	-3569000	Operating Cash Flow: -3569000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -1.1M 2010

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Free cash flow	-8662000	Operating Cash Flow: -7118000 Open source Capital Expenditure: 1544000 Open source
20092009-12-31	Free cash flow	-1647000	Operating Cash Flow: -1637000 Open source Capital Expenditure: 10000 Open source
20102010-12-31	Free cash flow	-1121000	Operating Cash Flow: -1121000 Open source Capital Expenditure: 0 Open source
20112011-12-31	Free cash flow	Unavailable	Operating Cash Flow: -719000 Open source
20122012-12-31	Free cash flow	Unavailable	Operating Cash Flow: -685000 Open source
20132013-12-31	Free cash flow	Unavailable	Operating Cash Flow: -404000 Open source
20142014-12-31	Free cash flow	Unavailable	Operating Cash Flow: -891000 Open source
20152015-12-31	Free cash flow	Unavailable	Operating Cash Flow: -388000 Open source
20162016-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1091000 Open source
20172017-12-31	Free cash flow	Unavailable	Operating Cash Flow: -3569000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

63.8% 2017

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2008-12-31	Liabilities / assets	Not reported	Total Assets: 3956000 Open source
2009-12-31	Liabilities / assets	Not reported	Total Assets: 2868000 Open source
2010-12-31	Liabilities / assets	Not reported	Total Assets: 2057000 Open source
2011-12-31	Liabilities / assets	Not reported	Total Assets: 392000 Open source
2012-12-31	Liabilities / assets	Not reported	Total Assets: 262000 Open source
20132013-12-31	Liabilities / assets	67.9%	Total Liabilities: 5546000 Open source Total Assets: 8170000 Open source
20142014-12-31	Liabilities / assets	54.8%	Total Liabilities: 10213000 Open source Total Assets: 18644000 Open source
20152015-12-31	Liabilities / assets	50.1%	Total Liabilities: 9212000 Open source Total Assets: 18378000 Open source
20162016-12-31	Liabilities / assets	54.3%	Total Liabilities: 9547000 Open source Total Assets: 17570000 Open source
20172017-12-31	Liabilities / assets	63.8%	Total Liabilities: 10181000 Open source Total Assets: 15956000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.92× 2017

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Current assets / current liabilities	0.51×	Current Assets: 1815000 Open source Current Liabilities: 3558000 Open source
20092009-12-31	Current assets / current liabilities	0.13×	Current Assets: 635000 Open source Current Liabilities: 4983000 Open source
20102010-12-31	Current assets / current liabilities	0.03×	Current Assets: 155000 Open source Current Liabilities: 5797000 Open source
20112011-12-31	Current assets / current liabilities	0×	Current Assets: 30000 Open source Current Liabilities: 6564000 Open source
20122012-12-31	Current assets / current liabilities	0.02×	Current Assets: 183000 Open source Current Liabilities: 7534000 Open source
20132013-12-31	Current assets / current liabilities	1.54×	Current Assets: 6109000 Open source Current Liabilities: 3975000 Open source
20142014-12-31	Current assets / current liabilities	0.85×	Current Assets: 5790000 Open source Current Liabilities: 6799000 Open source
20152015-12-31	Current assets / current liabilities	0.92×	Current Assets: 5646000 Open source Current Liabilities: 6161000 Open source
20162016-12-31	Current assets / current liabilities	0.73×	Current Assets: 5344000 Open source Current Liabilities: 7347000 Open source
20172017-12-31	Current assets / current liabilities	0.92×	Current Assets: 3464000 Open source Current Liabilities: 3782000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2008 2008-01-01 – 2008-12-31	−USD 6.33 million Exact value Exact value: -6328000 USD 2008-01-01 – 2008-12-31: -6328000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CytoCore Inc · 2008-12-31 CytoCore Inc (edgar:75439) Net Income: -6328000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6328000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/0000950123-10-050468.txt#20306 The citation records this snapshot. The page link may show a newer release later.	−USD 7.12 million Exact value Exact value: -7118000 USD 2008-01-01 – 2008-12-31: -7118000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CytoCore Inc · 2008-12-31 CytoCore Inc (edgar:75439) Operating Cash Flow: -7118000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7118000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/0000950123-10-050468.txt#20924 The citation records this snapshot. The page link may show a newer release later.	USD 1.54 million Exact value Exact value: 1544000 USD 2008-01-01 – 2008-12-31: 1544000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CytoCore Inc · 2008-12-31 CytoCore Inc (edgar:75439) Capital Expenditure: 1544000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1544000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/0000950123-10-050468.txt#21046 The citation records this snapshot. The page link may show a newer release later.	−USD 8.66 million Calculation and evidence -7118000 − 1544000 USD Exact free cash flow: -8662000 USD 2008-01-01 – 2008-12-31: -7118000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 1544000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CytoCore Inc · 2008-12-31 CytoCore Inc (edgar:75439) Free cash flow: -8662000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7118000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/0000950123-10-050468.txt#20924 Input fundies:CapitalExpenditure: 1544000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/0000950123-10-050468.txt#21046 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 3.55 million Exact value Exact value: -3552000 USD 2009-01-01 – 2009-12-31: -3552000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CytoCore Inc · 2009-12-31 CytoCore Inc (edgar:75439) Net Income: -3552000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3552000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/0000950123-11-035543.txt#7665 The citation records this snapshot. The page link may show a newer release later.	−USD 1.64 million Exact value Exact value: -1637000 USD 2009-01-01 – 2009-12-31: -1637000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CytoCore Inc · 2009-12-31 CytoCore Inc (edgar:75439) Operating Cash Flow: -1637000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1637000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/0000950123-11-035543.txt#7927 The citation records this snapshot. The page link may show a newer release later.	USD 10,000 Exact value Exact value: 10000 USD 2009-01-01 – 2009-12-31: 10000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CytoCore Inc · 2009-12-31 CytoCore Inc (edgar:75439) Capital Expenditure: 10000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/0000950123-11-035543.txt#7969 The citation records this snapshot. The page link may show a newer release later.	−USD 1.65 million Calculation and evidence -1637000 − 10000 USD Exact free cash flow: -1647000 USD 2009-01-01 – 2009-12-31: -1637000 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 10000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CytoCore Inc · 2009-12-31 CytoCore Inc (edgar:75439) Free cash flow: -1647000 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1637000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/0000950123-11-035543.txt#7927 Input fundies:CapitalExpenditure: 10000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/0000950123-11-035543.txt#7969 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 2.1 million Exact value Exact value: -2097000 USD 2010-01-01 – 2010-12-31: -2097000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CytoCore Inc · 2010-12-31 CytoCore Inc (edgar:75439) Net Income: -2097000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2097000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000114420412021999/cyoe-20111231.xml#26911 Filing: 000114420412021999 The citation records this snapshot. The page link may show a newer release later.	−USD 1.12 million Exact value Exact value: -1121000 USD 2010-01-01 – 2010-12-31: -1121000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CytoCore Inc · 2010-12-31 CytoCore Inc (edgar:75439) Operating Cash Flow: -1121000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1121000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000114420412021999/cyoe-20111231.xml#24270 Filing: 000114420412021999 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2010-01-01 – 2010-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CytoCore Inc · 2010-12-31 CytoCore Inc (edgar:75439) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/0000950123-11-035543.txt#7969 The citation records this snapshot. The page link may show a newer release later.	−USD 1.12 million Calculation and evidence -1121000 − 0 USD Exact free cash flow: -1121000 USD 2010-01-01 – 2010-12-31: -1121000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CytoCore Inc · 2010-12-31 CytoCore Inc (edgar:75439) Free cash flow: -1121000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1121000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000114420412021999/cyoe-20111231.xml#24270 Filing: 000114420412021999 Input fundies:CapitalExpenditure: 0 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/0000950123-11-035543.txt#7969 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 2.88 million Exact value Exact value: -2876000 USD 2011-01-01 – 2011-12-31: -2876000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CytoCore Inc · 2011-12-31 CytoCore Inc (edgar:75439) Net Income: -2876000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2876000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000114420413019354/cyoe-20121231.xml#102695 Filing: 000114420413019354 The citation records this snapshot. The page link may show a newer release later.	−USD 719,000 Exact value Exact value: -719000 USD 2011-01-01 – 2011-12-31: -719000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CytoCore Inc · 2011-12-31 CytoCore Inc (edgar:75439) Operating Cash Flow: -719000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -719000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000114420413019354/cyoe-20121231.xml#109919 Filing: 000114420413019354 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2012 2012-01-01 – 2012-12-31	−USD 1.51 million Exact value Exact value: -1514000 USD 2012-01-01 – 2012-12-31: -1514000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CytoCore Inc · 2012-12-31 CytoCore Inc (edgar:75439) Net Income: -1514000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1514000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000114420414022503/cyoe-20131231.xml#93649 Filing: 000114420414022503 The citation records this snapshot. The page link may show a newer release later.	−USD 685,000 Exact value Exact value: -685000 USD 2012-01-01 – 2012-12-31: -685000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CytoCore Inc · 2012-12-31 CytoCore Inc (edgar:75439) Operating Cash Flow: -685000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -685000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000114420414022503/cyoe-20131231.xml#98927 Filing: 000114420414022503 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2013 2013-01-01 – 2013-12-31	USD 54,000 Exact value Exact value: 54000 USD 2013-01-01 – 2013-12-31: 54000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CytoCore Inc · 2013-12-31 CytoCore Inc (edgar:75439) Net Income: 54000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: 54000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000114420415029402/mdit-20141231.xml#96013 Filing: 000114420415029402 The citation records this snapshot. The page link may show a newer release later.	−USD 404,000 Exact value Exact value: -404000 USD 2013-01-01 – 2013-12-31: -404000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CytoCore Inc · 2013-12-31 CytoCore Inc (edgar:75439) Operating Cash Flow: -404000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -404000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000114420415029402/mdit-20141231.xml#97225 Filing: 000114420415029402 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2014-01-01 – 2014-12-31	−USD 699,000 Exact value Exact value: -699000 USD 2014-01-01 – 2014-12-31: -699000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CytoCore Inc · 2014-12-31 CytoCore Inc (edgar:75439) Net Income: -699000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -699000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000141588916005503/mdit-20151231.xml#84122 Filing: 000141588916005503 The citation records this snapshot. The page link may show a newer release later.	−USD 891,000 Exact value Exact value: -891000 USD 2014-01-01 – 2014-12-31: -891000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CytoCore Inc · 2014-12-31 CytoCore Inc (edgar:75439) Operating Cash Flow: -891000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -891000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000141588916005503/mdit-20151231.xml#92140 Filing: 000141588916005503 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2015-01-01 – 2015-12-31	−USD 859,000 Exact value Exact value: -859000 USD 2015-01-01 – 2015-12-31: -859000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CytoCore Inc · 2015-12-31 CytoCore Inc (edgar:75439) Net Income: -859000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -859000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000165495417003300/mdit-20161231.xml#505191 Filing: 000165495417003300 The citation records this snapshot. The page link may show a newer release later.	−USD 388,000 Exact value Exact value: -388000 USD 2015-01-01 – 2015-12-31: -388000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CytoCore Inc · 2015-12-31 CytoCore Inc (edgar:75439) Operating Cash Flow: -388000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -388000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000165495417003300/mdit-20161231.xml#542262 Filing: 000165495417003300 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2016-01-01 – 2016-12-31	−USD 2.16 million Exact value Exact value: -2163000 USD 2016-01-01 – 2016-12-31: -2163000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CytoCore Inc · 2016-12-31 CytoCore Inc (edgar:75439) Net Income: -2163000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2163000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000165495418005606/mdit-20171231.xml#90975 Filing: 000165495418005606 The citation records this snapshot. The page link may show a newer release later.	−USD 1.09 million Exact value Exact value: -1091000 USD 2016-01-01 – 2016-12-31: -1091000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CytoCore Inc · 2016-12-31 CytoCore Inc (edgar:75439) Operating Cash Flow: -1091000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1091000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000165495418005606/mdit-20171231.xml#96347 Filing: 000165495418005606 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2017-01-01 – 2017-12-31	−USD 6.81 million Exact value Exact value: -6811000 USD 2017-01-01 – 2017-12-31: -6811000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CytoCore Inc · 2017-12-31 CytoCore Inc (edgar:75439) Net Income: -6811000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6811000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000165495418005606/mdit-20171231.xml#90850 Filing: 000165495418005606 The citation records this snapshot. The page link may show a newer release later.	−USD 3.57 million Exact value Exact value: -3569000 USD 2017-01-01 – 2017-12-31: -3569000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CytoCore Inc · 2017-12-31 CytoCore Inc (edgar:75439) Operating Cash Flow: -3569000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T12:03:03Z Snapshot: 45a5b5ed28cca2766bb4405f888912c04c359bf1a8b2472edf40c372df5cfffc Dimensions: Consolidated View: https://fundies.io/companies/edgar/75439/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3569000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/75439/000165495418005606/mdit-20171231.xml#96164 Filing: 000165495418005606 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

119 filings · 2,651 latest values · 2,651 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000075439, 75439, CYOE, MDIT, cyoe, edgar:75439

Also known as AMPERSAND MEDICAL CORP, BELL NATIONAL CORP, CYTOCORE INC, CytoCore Inc, Cytocore Inc, MEDITE CANCER DIAGNOSTICS, INC., MOLECULAR DIAGNOSTICS INC, Medite Cancer Diagnostics, Inc.

CytoCore Inc

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2017 2017-01-01 – 2017-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation